Indefinite Delivery Contract 75N95024D00022
Award Date
6/20/24
Last Date to Order
11/25/24
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Mriglobal
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The National Center for Advancing Translational Sciences (NCATS), a civilian agency, has awarded an indefinite delivery contract (IDC) worth up to $48,622,546 to Charles River Laboratories, Inc. to provide safety evaluation and toxicology studies and related services to support drug development. The contract has a period of performance from August 2024 to August 2030. Under this IDC, Charles River will perform in vitro and in vivo exploratory and Investigational New Drug (IND)-directed...
This is a multiple award indefinite delivery contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to conduct safety evaluation and toxicology studies to support drug development. The $48.6 million contract has a 6-year ordering period from June 2024 to June 2030. The contractor, IIT Research Institute (IITRI), a non-profit research organization, will perform in vitro and in vivo exploratory and...
The federal contract IDV award is for safety evaluation and toxicology studies and related services to support drug development efforts of the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The prime contractor, SRI International, a nonprofit research and development institute, will provide in vitro and in vivo exploratory and Investigational New Drug (IND)-directed toxicology studies for small molecule and biologic...
This indefinite delivery contract was awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Mriglobal, a 501(c)(3) not-for-profit research organization, with a potential value of $49,713,679. The contract is for Chemistry, Manufacturing and Controls (CMC) and related services to support the development of drug substances for the Division of Preclinical Innovation's translational research programs. The contract...
This indefinite delivery contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Lovelace Biomedical Research Institute, a not-for-profit contract research organization. The $48.6 million multiple-award IDC has a 6-year ordering period from June 2024 to June 2030. The contract aims to procure safety evaluation and toxicology studies and related services to support drug development efforts at NCATS....
This indefinite delivery contract was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the U.S. Department of Health and Human Services, to Lovelace Biomedical Research Institute, a not-for-profit contract research organization based in Albuquerque, New Mexico. The $17.89 million multiple-award contract, which runs through April 2025, is for contract research organization (CRO) support for NCATS' medicinal chemistry work focused on lead optimization. Under the...
The Department of Health and Human Services' National Center for Advancing Translational Sciences (NCATS) has issued a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract valued at up to $49,885,703 to support Chemistry, Manufacturing, and Control (CMC) services for drug product development. The 7-year contract was awarded to Fisher Bioservices Inc.'s Clinical Trials Division, a subsidiary of Thermo Electron Corporation. The contract scope includes a wide range of CMC services...
This Indefinite Delivery Contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, to the prime contractor Southern Research Institute, a non-profit research organization located in Birmingham, Alabama. The IDC, with a ceiling value of $17,891,012, is to provide CRO (Contract Research Organization) support for NCATS' Medicinal Chemistry for Lead Optimization program. This includes services...
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, awarded an Indefinite Delivery Contract (IDC) valued up to $17,887,012 to Organix Chemistry Solutions LLC for CRO Support for NCATS Medicinal Chemistry for Lead Optimization. Under this multiple-award IDC, Organix was issued two delivery orders to date. The first delivery order, valued at $3,677,412.09, provides synthetic chemistry support services to NCATS'...
This indefinite delivery contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Sri International, a non-profit research institute. The $3.9 million contract supports NCATS' drug development programs by (1) developing and validating sensitive bioanalytical methods to quantify concentrations of novel biologics, (2) developing assays to measure anti-drug antibodies, and (3)...